Ares Capital: Strong Buy Rating Justified by Robust Q2 Performance and Undervalued Shares
Finance

Ares Capital: Strong Buy Rating Justified by Robust Q2 Performance and Undervalued Shares

authorBy Robert Kiyosaki
DateAug 04, 2026
Read time1 min

Ares Capital (ARCC) continues to hold a prominent position within my business development company (BDC) portfolio, reflecting my strong confidence in its performance. Although the company has experienced a steady decline in its stock price over several quarters, its latest quarterly earnings report provides a compelling case for optimism.

The second quarter results for ARCC demonstrated remarkable strength, characterized by stable non-accruals, a net investment income that surpasses many of its industry peers, and robust dividend coverage. These factors collectively indicate the company's resilient operational health and its capacity to sustain shareholder returns. Furthermore, ARCC shares are currently trading at a discount, below 1.0 times their book value. This valuation suggests a significant upside potential for investors, offering double-digit total returns even in a scenario where a slight dividend cut might occur.

Considering its strong financial performance in the most recent quarter and its current undervaluation in the market, Ares Capital is an attractive investment opportunity. The company's stable credit performance and impressive dividend coverage underpin its potential for long-term growth and investor returns. Therefore, upgrading ARCC to a strong buy rating is warranted.

More Articles
Finance
Global Market Index Forecasts Indicate Upward Trend
The Global Market Index (GMI) shows an increasing trend in its expected total returns for July, marking a continuation of recent positive revisions. Despite this improvement, the projected long-term returns for GMI remain below its performance over the past decade, though the disparity is progressively narrowing.
By Suze OrmanAug 04, 2026
Finance
IQVIA's Remarkable Q2 Performance Driven by Clinical Research Backlog
IQVIA Holdings Inc. (NYSE: IQV) reported exceptional second-quarter 2026 results, surpassing financial projections and demonstrating robust growth in clinical research. The company's significant backlog in R&D solutions and strong free cash flow generation highlight its prominent position in the evolving healthcare ecosystem, propelled by increasing biopharma outsourcing and AI integration in trials.
By Suze OrmanAug 04, 2026
Finance
Alphabet's Strategic Capital Expenditure and AI-Driven Growth
Alphabet Inc. (GOOGL) has received a reaffirmed Strong Buy rating due to its aggressive capital expenditure and accelerating growth in AI and cloud services. The company reported a 24% year-over-year revenue increase to $119.8 billion and a 160 basis point margin expansion, with cloud revenues soaring by 82% year-over-year. Management has increased full-year CapEx guidance to $195–205 billion, emphasizing long-term returns despite a near-term negative free cash flow. The valuation remains attractive at 24 times its 2027 estimated earnings multiple and approximately 1x PEG, suggesting that consensus estimates might be overly pessimistic.
By Fareed ZakariaAug 04, 2026
Finance
S&P 500: A Resilient Market Outlook Amidst Shifting Valuations
Despite a challenging July for the S&P 500, underlying market strengths, including robust earnings forecasts and the resilience of the equal-weight index, suggest a positive trajectory. Valuations for leading tech companies have reached attractive levels, potentially setting the stage for a renewed rally by year-end. While near-term volatility is anticipated, strategic investments, particularly in AI-driven sectors, are poised for growth.
By Suze OrmanAug 04, 2026
Finance
Snap's Financial Revival: A Deep Dive into Q2 Earnings and Future Prospects
Snap (SNAP) recently announced strong Q2 earnings, surpassing revenue expectations and showcasing significant margin improvements. This positive performance, driven by enhanced advertising products and operational efficiencies, led to a notable post-earnings stock rally. Despite stagnant user growth in North America, international expansion and a stable US market offer a more optimistic outlook. The company's valuation, currently at 6.9x EV/FTM EBITDA, is considerably lower than its industry peers, prompting an upgrade to a 'neutral' rating, while acknowledging potential risks from user growth challenges and regulatory scrutiny.
By Suze OrmanAug 04, 2026